Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: Is the prison vaccination programme driving recent improvements?

Journal of Viral Hepatitis

Volumn 14, Issue 9, 2007, Pages 653-660

  Hope, V D ^a,b   Ncube, F ^a   Hickman, M ^c   Judd, A ^d   Parry, J V ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Hepatitis B; Injecting drug users; United Kingdom; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; COMMUNITY CARE; DRUG USE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; UNITED KINGDOM; VACCINATION;

ADULT; ENGLAND; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; PRISONERS; SUBSTANCE ABUSE, INTRAVENOUS; VACCINATION;

EID: 34547917959     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00856.x     Document Type: Article

References (25)

1. Des Jarlais DC, Fisher DG, Newman JC et al. Providing Hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a Syringe Exchange Program. Am J Public Health 2001 91 (11 1791 1792.
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004 11 : 97 107.
3. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and the UASSG. Shooting Up: Infections among Injecting Drug Users in the United Kingdom 2004. London : Health Protection Agency, 2005 ISBN 0 901144 76 2.
4. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 337 : 1733 1745.
5. WHO. Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 2004 79 : 255 263. Available at http://www.who.int/immunization/ wer7928HepB_July04_position_paper.pdf.
6. Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales. Commun Dis Public Health 2001 4 : 71 72.
7. NHS Executive. Drug Misuse Special Allocation: 1999/2000 Funding and Guidance on the Modernisation Fund Element. London, UK : NHS Executive, HSC 1999/036.
8. Gilbert RL, Costella A, Piper M, Gill N. Increasing Hepatitis B vaccine coverage in prisons in England & Wales. Commun Dis Public Health 2004 7 : 306 311.
9. Allwright S, Bradley F, Barry J, Long J, Thornton L, Parry JV. Hepatitis B, hepatitis C and HIV antibody prevalence and risk factors in Irish prisoners: results of a national cross-sectional survey. Br Med J 2000 321 : 78 82.
10. Heptonstall J. Strategies for delivering hepatitis B vaccine to injecting drug users. Commun Dis Public Health 1999 2 : 154 156 A, Hickman M, Hope VD et al. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales Parallel submission to J Viral Hepatitis. doi : (in press).
11. Prison Infection Prevention team. Prison Hepatitis B Vaccination Programme Monitoring, 2003-2006. London, UK. 2006 : Prison Infection Prevention team. Available at http://www.hpa.org.uk/infections/topics_az/prisons/prisons. htm.
12. Hutchinson SJ, Wadd S, Taylor A et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccination programme in prisons. Vaccine 2004 23 : 210 214.
13. Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gill ON. Modelling the characteristics of the males injecting drug user population in England and Wales. Int J Drug Policy 2005 16 : 176 182.
14. Sutton AJ, Gay NJ, Edmunds WJ et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiol Infect 2006 134 : 231 242.
15. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 2004 29 (4 211 220.
16. Altice FL, Bruce RD, Walton MR, Buitrago MI. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health 2005 82 : 151 161.
17. Bock HL, Loscher T, Scheiermann N et al. Accelerated schedule for Hepatitis B immunisation. J Travel Med 1995 2 : 213 217.
18. Lum PJ, Ochoa KC, Han JA et al. Immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health 2003 93 : 919 923.
19. Judd A, Parry JV, Hickman M et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003 71 : 49 55.
20. Cook PA, McVeigh J, Syed Q, Mutton K, Bellis M. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction 2001 96 : 1787 1797.
21. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol 1996 143 : 725 732.
22. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993 88 : 517 526.
23. Kuo I, Mudrick DW, Strathdee SA, Thomas DL, Sherman SG. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users. Clin Infect Dis 2004 38 : 587 590.
24. Kuo I, Sherman SG, Thomas DL, Strathdee SA. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend 2004 73 : 69 78.
25. Perrett K, Granerod J, Crowcroft N, Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users Commun Dis Public Health 2003 6 (2 97 100.